Amneal Pharmaceuticals, Inc. (AMRX)
NASDAQ: AMRX · Real-Time Price · USD
11.35
+0.15 (1.34%)
At close: Nov 4, 2025, 4:00 PM EST
11.45
+0.10 (0.88%)
Pre-market: Nov 5, 2025, 7:10 AM EST
Amneal Pharmaceuticals Market Cap
Amneal Pharmaceuticals has a market cap or net worth of $3.56 billion as of November 5, 2025. Its market cap has increased by 36.13% in one year.
Market Cap
3.56B
Enterprise Value
6.05B
1-Year Change
36.13%
Ranking
Category
Stock Price
$11.35
Market Cap Chart
Since March 27, 2018, Amneal Pharmaceuticals's market cap has decreased from $5.76B to $3.56B, a decrease of -38.12%. That is a compound annual growth rate of -6.11%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2025 | 3.52B | 43.28% |
| Dec 31, 2024 | 2.45B | 31.89% |
| Dec 29, 2023 | 1.86B | 208.01% |
| Dec 30, 2022 | 604.10M | -58.17% |
| Dec 31, 2021 | 1.44B | 5.42% |
| Dec 31, 2020 | 1.37B | -4.99% |
| Dec 31, 2019 | 1.44B | -64.31% |
| Dec 31, 2018 | 4.04B | -29.87% |
| Mar 27, 2018 | 5.76B | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 811.99B |
| Johnson & Johnson | 450.20B |
| AbbVie | 381.38B |
| UnitedHealth Group | 299.68B |
| AstraZeneca | 253.45B |
| Novartis AG | 240.68B |
| Abbott Laboratories | 218.75B |
| Novo Nordisk | 215.64B |